Osteoporosis in paediatrics

Archives of Disease in Childhood: Education and Practice Edition

Volumn 92, Issue 6, 2007, Pages

  Shaw, N J ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 7; LYMPHOTOXIN; OLPADRONIC ACID; PAMIDRONIC ACID; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ALBERS SCHOENBERG DISEASE; BONE BIOPSY; BONE DENSITOMETRY; BONE DENSITY; BONE DEVELOPMENT; BONE FRAGILITY; BONE MALFORMATION; BONE METABOLISM; CEREBRAL PALSY; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; GASTROINTESTINAL SYMPTOM; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LEUKEMIA; MALNUTRITION; NEPHROTIC SYNDROME; OSTEOGENESIS IMPERFECTA; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WALKING DIFFICULTY; WORLD HEALTH ORGANIZATION;

ABSORPTIOMETRY, PHOTON; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; CYTOKINES; FRACTURES, BONE; GLUCOCORTICOIDS; HUMANS; INFANT; OSTEOPOROSIS;

EID: 36849042579     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2006.105791     Document Type: Review

References (43)

1. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group, WHO Technical Report Series 843. Geneva: WHO, 1994.
2. Goulding A, Cannan R, Williams SM, et al. BMD in girls with forearm fractures. J Bone Miner Res 1998;13:143-8.
3. Clark EM, Ness AR, Bishop NJ, et al. Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 2006;21:1489-95.
4. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004;363:1377-85.
5. Morello R, Bertin TK, Chen Y, et al. CRTAP is required for prolyl 3-hydroxylatian and mutations cause recessive osteogenesis imperfecta. Cell 2006;127:291-304.
6. Hartikka H, Makitie O, Mannikko M, et al. Heterozygous mutations in the LDL receptor related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 2005;20:783-9.
7. Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001;107:513-23.
8. Stevenson RD, Conaway M, Barrington JW, et al. Fracture rate in children with cerebral palsy. Pediatr Rehabil 2006;9:396-403.
9. Binkley T, Johnson J, Vogel L, et al. Bone measurements by peripheral quantitative computed tomography(pQCT) in children with cerebral palsy. J Pediatr 2005;147:791-6.
10. Larson CM, Henderson RC. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 2000;20:71-4.
11. Sylvester FA, Davis PM, Wyzga N, et al. Are activated T cells regulators of bone metabolism in children with Crohn disease? J Pediatr 2006;148:461-6.
12. Thearle M, Horlick M, Bilezikian JP, et al. Osteoporosis: an unusual presentation of childhood Crohn's disease. J Clin Endocrinol Metab 2000;85:2122-6.
13. Varonos S, Ansell BM, Reeve J. Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy. Calcif Tissue Int 1987;41:75-8.
14. van Staa TP, Cooper C, Leufkens HG, et al. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 2003;18:913-18.
15. Leonard MB, Feldman HI, Shults J, et al. Long-term, high dose glucocorticoids and bone mineral content in childhood glucocorticoid sensitive nephritic syndrome. N Engl J Med 2004;351:868-75.
16. Bielinski BK, Darbyshire PJ, Mathers L, et al. Impact of disordered puberty on bone density in β thalassaemia major. Br J Haemat 2003;120:353-8.
17. Hogler W, Briody J, Moore B, et al. Importance of oestrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J Clin Endocrinol Metab 2004;89:193-9.
18. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Altered bone density and body composition, and increased fracture risk in childhood acute lymphoblastic leukaemia. J Pediatr 2002;141:204-10.
19. Makitie O, Doria AS, Henriques F, et al. Radiographic vertebral morphometry: a diagnostic tool in pediatric osteoporosis. J Pediatr 2005;146:395-401.
20. Brenner RE, Schiller B, Vetter U, et al. Serum concentrations of procollagen 1 C-terminal propeptide, osteocalcin and insulin-like growth factor-1 in patients with non-lethal osteogenesis imperfecta. Acta Paediatr 1993;82:764-7.
21. Rauch F, Travers R, Norman ME, et al. Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellous iliac bone. J Bone Miner Res 2000;15:957-63.
22. Leonard MB, Propert KJ, Zemel BS, et al. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr 1999;135:182-8.
23. Gafni R, Baron J. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy X-ray absorptiometry (DEXA). J Pediatr 2004;144:253-7.
24. Van der Sluis IM, de Ridder MAJ, Boot AM, et al. Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child 2002;87:341-7.
25. Ward KA, Ashby RL, Roberts SA, et al. UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years. Arch Dis Child 2007;92:53-9.
26. Molgaard C, Thomsen BL, Prentice A, et al. Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 1997;76:9-15.
27. Crabtree NJ, Kibirige MS, Fordham J, et al. The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone 2004;35:965-72.
28. Adams JE, Shaw N, eds. A practical guide to bone densitometry in children. First edition. Bath, UK: National Osteoporosis Society, 2004.
29. Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000;2:CD000952.
30. Caulton JM, Ward KA, Alsop CW, et al. A randomised controlled trial of standing programme on bone mineral density in non-ambulant children with cerebral palsy. Arch Dis Child 2004;89:131-5.
31. Chad K, Bailey D, McKay H, et al. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr 1999;135:115-17.
32. Ward K, Alsop C, Caulton J, et al. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res 2004;19:360-9.
33. Finkelstein JS, Klibanski A, Neer RM, et al. Increases in bone density during treatment of men with idiopathic hypogonadotrophic hypogonadism. J Clin Endocrinol Metab 1989;69:776-83.
34. Henderson RC, Lark RK, Kecskemethy HH, et al. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomised, placebocontrolled clinical trial. J Pediatr 2002;141:644-51.
35. Bechtold S, Ripperger W, Bonfig R, et al. Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 2005;90:3168-73.
36. Glorieux FH, Bishop NJ, Plotkin H, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998;339:947-52.
37. Sakkers R, Kok D, Engelbert R, et al. Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2 year randomised placebo-controlled study. Lancet 2004;363:1427- 31.
38. Grissom LE, Kecskemethy HH, Bachrach SJ, et al. Bone densitometry in pediatric patients treated with pamidronate. Pediatr Radiol 2005;35:511-17.
39. Munns CF, Rauch F, Zeirlin L, et al. Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 2004;19:1779-86.
40. Papapoulos SE, Cremers SCLM. Prolonged bisphosphonate release after treatment in children. N Engl J Med 2007;356:1075-76.
41. Ward KA, Adams JE, Freemont TJ, et al. Can bisphosphonate treatment be stopped in a growing child with skeletal fragility? Osteoporos Int 2007;18:1137-40.
42. Bilezikian JP. Osteonecrosis of the jaw: do bisphosphonates pose a risk? N Engl J Med 2006;355:2278-81.
43. Whyte MP, Wenkert D, Clements KL, et al. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003;349:457- 63.